Fairmont Healthcare And Rehabilitation Center | |
130 Kaufman Drive, Fairmont, West Virginia 26554 | |
(304) 363-5633 | |
Name | Fairmont Healthcare And Rehabilitation Center |
---|---|
Location | 130 Kaufman Drive, Fairmont, West Virginia |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 120 |
Occupancy Rate | 86.92% |
Medicare ID (CCN) | 515189 |
Legal Business Name | Guardian Elder Care At Fairmont, Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1326439522 |
Organization Name | OAK HRC FAIRMONT LLC |
Doing Business As | FAIRMONT HEALTH AND REHABILITATION CENTER |
Address | 130 Kaufman Dr, Fairmont, WV 26554 |
Phone Number | 304-363-5633 |
News Archive
HealthLeaders-InterStudy and Fingertip Formulary find that the market growth of immune biologics will come from the expansion of indications for immune biologics in response to limited off-label use and competition for preferred status.
Writing in the Center for Global Development's blog, Victoria Fan, a research fellow at CGD, describes a panel session during the 4th Conference of the Consortium of Universities for Global Health recently held in Washington, D.C.
Joining me today is Dr. Mary Wakefield, administrator of the Health Resources and Services Administration (HRSA). An agency of the Department of Health and Human Services, HRSA is committed to improving access to healthcare services for some of our nation's most vulnerable citizens.
Two innovative programs designed to improve the availability of emerging medical technologies that can help patients receive more effective, efficient and personalized health care are advanced in a commentary written by a team of scientists and policy experts, including seven from Arizona State University, and published today in Science Translational Medicine.
› Verified 3 days ago
NPI Number | 1346274370 |
Organization Name | KAUFMAN STREET WV LLC |
Doing Business As | ARBORS AT FAIRMONT |
Address | 130 Kaufman Dr, Fairmont, WV 26554 |
Phone Number | 304-363-5633 |
News Archive
HealthLeaders-InterStudy and Fingertip Formulary find that the market growth of immune biologics will come from the expansion of indications for immune biologics in response to limited off-label use and competition for preferred status.
Writing in the Center for Global Development's blog, Victoria Fan, a research fellow at CGD, describes a panel session during the 4th Conference of the Consortium of Universities for Global Health recently held in Washington, D.C.
Joining me today is Dr. Mary Wakefield, administrator of the Health Resources and Services Administration (HRSA). An agency of the Department of Health and Human Services, HRSA is committed to improving access to healthcare services for some of our nation's most vulnerable citizens.
Two innovative programs designed to improve the availability of emerging medical technologies that can help patients receive more effective, efficient and personalized health care are advanced in a commentary written by a team of scientists and policy experts, including seven from Arizona State University, and published today in Science Translational Medicine.
› Verified 3 days ago
NPI Number | 1629584727 |
Organization Name | QLS FAIRMONT LLC |
Doing Business As | QUALITY LIFE SERVICES - FAIRMONT |
Address | 130 Kaufman Dr, Fairmont, WV 26554 |
Phone Number | 724-431-0700 |
News Archive
HealthLeaders-InterStudy and Fingertip Formulary find that the market growth of immune biologics will come from the expansion of indications for immune biologics in response to limited off-label use and competition for preferred status.
Writing in the Center for Global Development's blog, Victoria Fan, a research fellow at CGD, describes a panel session during the 4th Conference of the Consortium of Universities for Global Health recently held in Washington, D.C.
Joining me today is Dr. Mary Wakefield, administrator of the Health Resources and Services Administration (HRSA). An agency of the Department of Health and Human Services, HRSA is committed to improving access to healthcare services for some of our nation's most vulnerable citizens.
Two innovative programs designed to improve the availability of emerging medical technologies that can help patients receive more effective, efficient and personalized health care are advanced in a commentary written by a team of scientists and policy experts, including seven from Arizona State University, and published today in Science Translational Medicine.
› Verified 3 days ago
NPI Number | 1861998486 |
Organization Name | GUARDIAN ELDER CARE AT FAIRMONT LLC |
Doing Business As | FAIRMONT HEALTHCARE AND REHABILITATION CENTER |
Address | 130 Kaufman Dr, Fairmont, WV 26554 |
Phone Number | 340-363-5633 |
News Archive
HealthLeaders-InterStudy and Fingertip Formulary find that the market growth of immune biologics will come from the expansion of indications for immune biologics in response to limited off-label use and competition for preferred status.
Writing in the Center for Global Development's blog, Victoria Fan, a research fellow at CGD, describes a panel session during the 4th Conference of the Consortium of Universities for Global Health recently held in Washington, D.C.
Joining me today is Dr. Mary Wakefield, administrator of the Health Resources and Services Administration (HRSA). An agency of the Department of Health and Human Services, HRSA is committed to improving access to healthcare services for some of our nation's most vulnerable citizens.
Two innovative programs designed to improve the availability of emerging medical technologies that can help patients receive more effective, efficient and personalized health care are advanced in a commentary written by a team of scientists and policy experts, including seven from Arizona State University, and published today in Science Translational Medicine.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
HealthLeaders-InterStudy and Fingertip Formulary find that the market growth of immune biologics will come from the expansion of indications for immune biologics in response to limited off-label use and competition for preferred status.
Writing in the Center for Global Development's blog, Victoria Fan, a research fellow at CGD, describes a panel session during the 4th Conference of the Consortium of Universities for Global Health recently held in Washington, D.C.
Joining me today is Dr. Mary Wakefield, administrator of the Health Resources and Services Administration (HRSA). An agency of the Department of Health and Human Services, HRSA is committed to improving access to healthcare services for some of our nation's most vulnerable citizens.
Two innovative programs designed to improve the availability of emerging medical technologies that can help patients receive more effective, efficient and personalized health care are advanced in a commentary written by a team of scientists and policy experts, including seven from Arizona State University, and published today in Science Translational Medicine.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 11.69 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.71 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 56.4 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.71 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.29 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.52 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 71.36 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 10.5 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 23.98 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 3.33 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 16.48 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 28.17 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.96 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 95.59 | 95.98 |
Percentage of short-stay residents who made improvements in function | 75.21 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 41.46 | 82.93 |
News Archive
HealthLeaders-InterStudy and Fingertip Formulary find that the market growth of immune biologics will come from the expansion of indications for immune biologics in response to limited off-label use and competition for preferred status.
Writing in the Center for Global Development's blog, Victoria Fan, a research fellow at CGD, describes a panel session during the 4th Conference of the Consortium of Universities for Global Health recently held in Washington, D.C.
Joining me today is Dr. Mary Wakefield, administrator of the Health Resources and Services Administration (HRSA). An agency of the Department of Health and Human Services, HRSA is committed to improving access to healthcare services for some of our nation's most vulnerable citizens.
Two innovative programs designed to improve the availability of emerging medical technologies that can help patients receive more effective, efficient and personalized health care are advanced in a commentary written by a team of scientists and policy experts, including seven from Arizona State University, and published today in Science Translational Medicine.
› Verified 3 days ago
Tygart Center At Fairmont Campus Location: 1539 Country Club Road, Fairmont, West Virginia 26554 Phone: (304) 366-9100 | |
John Manchin Sr Health Care Center Location: 401 Guffey Street, Fairmont, West Virginia 26554 Phone: (304) 363-2500 | |
Pierpont Center At Fairmont Campus Location: 1543 Country Club Road, Fairmont, West Virginia 26554 Phone: (304) 363-2273 | |
Fairmont Healthcare And Rehabilitation Center Location: 130 Kaufman Drive, Fairmont, West Virginia 26554 Phone: (304) 363-5633 |